and extend our knowledge about a novel regulatory mechanism for maintaining Fc RI in a quiescent state.
although mast cell/basophil-induced reactions are diminished [7] [8] [9] . Specifi cally, Creticos et al. [1] showed that antigen-specifi c IgE levels do not decrease following allergy shots; instead antigen-specifi c IgE levels initially increase and do not fall below baseline/initial levels.
Instead, the intrinsic IgE-induced reactivity of basophils is reduced following immunotherapy. A recent study typifi es this observation where basophils were obtained before and after immunotherapy and challenged with antigen, anti-IgE, or non-IgE-mediated stimuli; extracellular serum concentrations of IgE/IgG were not a factor in these experiments [9] . Fc RI-mediated basophil histamine release was signifi cantly reduced following allergen immunotherapy and no decrease in antigen-specifi c IgE levels was noted [9] . Therefore, while basophil Fc RI nonresponsiveness is induced during immunotherapy, there is a paradoxical rise in allergen-specifi c IgE in the serum suggesting that a simple reduction in allergen-specifi c IgE cannot explain its effi cacy.
Like basophils, mast cell nonresponsiveness occurs in patients who have undergone successful allergen immunotherapy where a reduction in the skin prick test, which measures skin mast cell IgE-mediated degranulation in response to antigen challenge, is a strong predictor for clinical effi cacy [10] . Similarly, patients allergic to certain drugs (i.e. penicillin) can be 'rush' desensitized by injection of the drug at concentrations that do not trigger an allergic response [11] .
While it is clear that mast cells and basophils are capable of being induced to nonresponsiveness by certain in vivo and in vitro scenarios, the mechanisms leading to Fc RI nonresponsiveness are not known. It was hypothesized, based on the observation that the phenotype of IgE nonresponsive mast cells and basophils was similar to naturally occurring, Syk-defi cient 'nonreleaser' basophils [12] and lung mast cells [13] , that antigen stimulation could induce Fc RI nonresponsiveness and Syk protein reduction. We challenged human skin mast cells with optimal and suboptimal concentrations of antigen and measured mediator release and Syk expression. We show that the induction of IgE nonresponsive skin mast cells and peripheral blood basophils correlates with reduced Syk protein levels. Suboptimal antigen stimulation of freshly purifi ed peripheral blood basophils also resulted in reduced Syk levels. These data suggest that human Fc RI nonresponsiveness is linked to the levels of Syk which can be dramatically reduced in suboptimally challenged cells.
Materials and Methods

Reagents
Monoclonal antiphosphotyrosine (pY) and anti-Lyn Abs were obtained from Santa Cruz Biotechnology, Santa Cruz, Calif., USA. Antiactin was from Sigma, St. Louis, Mo., USA. The anti-Syk, antiCbl, and anti-Fc RI-␥ Ab were obtained from Upstate, Lake Placid, N.Y., USA. The chimeric human anti-4-hydroxy-3-nitrophenacetyl (NP) IgE Ab and the antigen it detects, NP-BSA, were from Serotec (Oxford, UK) or purifi ed from the cell line JW8 (ATCC, Fairfax, Va., USA). IgE is centrifuged at 60,000 g to remove any aggregates. The proteasome inhibitors PSI and MG-132 were from Calbiochem, San Diego, Calif., USA. The antibody 22E7 to the Fc RI-␣ chain was a generous gift from Dr. J. Kochan.
Tissue Mast Cells
Skin mast cells were purifi ed and cultured as described [14] . Fresh samples of skin or lung were obtained from surgical specimens at the Virginia Commonwealth University Health Systems or through the Cooperative Human Tissue Network of the National Cancer Institute (Columbus, Ohio, USA). All studies were approved by the Human Studies Committee at Virginia Commonwealth University Health Systems. Tissue was cut into fragments and incubated in a solution containing collagenase, hyaluronidase DNase, and 1% fetal calf serum (digestion buffer) for 2 h at 37 ° C with constant stirring. The dispersed cells were separated from residual tissue by fi ltration and suspended in HBSS containing 1% FCS and 10 m M 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (HEPES; washing buffer). The remaining tissue was subjected to two additional digestions as above, and combined with the cells from the fi rst digestion. Cells were resuspended in washing buffer, layered over Histopaque and centrifuged at 700 g at room temperature for 20 min.
Enriched skin cells were suspended at 1 ! 10 6 cells/ml in serumfree AIM-V medium (Life Technologies, Rockville, Md., USA) containing 100 ng/ml rhuSCF (Biosource) in 24-well plates (Costar). When the cell number reached approximately 2 ! 10 6 cells/ml, half the cells were split to another well with fresh medium. Cell numbers per sample were adjusted to account for the cells that were split. Total cell number and viability were assessed by trypan blue staining. Cultures were maintained for up to 2 months and were approximately 100% skin mast cells.
Peripheral Blood Basophils
Venous blood (100-300 ml) was collected from healthy, nonmedicated donors who had given informed consent. Basophils were purifi ed as previously described [15, 16] .
Measurement of Degranulation and Cytokine Production
All samples were run in duplicate. Mast cells were sensitized with human anti-NP IgE (1-5 g/ml) for at least 24 h. In some experiments, the proteasome inhibitors PSI or MG-132 (10-100 M ) were added to the cells 30 min prior to activation. Duplicate samples (1-5 ! 10 5 cells/condition) were washed and activated in AIM-V media plus 100 g/ml of soybean trypsin inhibitor with or without NP-BSA. After 30 min, cells were centrifuged and 25 l of media removed for ␤ -hexosaminidase measurement [17] . Cells were suspended in the remaining media and incubated in a CO 2 incubator for 24-52 h. Cells were centrifuged and the supernatants stored at -70 ° C until cytokine measurement. In some experiments
IgE-sensitized cells were incubated for 30 h with suboptimal concentrations (0.01-0.1 ng/ml) of NP-BSA, washed and rechallenged as above. Cytokines were measured using an in-house ELISA. Briefl y, granulocyte monocyte-colony-stimulating factor (GM-CSF) or tumor necrosis factor-␣ (TNF-␣ ) Abs (Pharmingen, San Diego, Calif., USA) were diluted in PBS/1% BSA/Tween (2 g/ml) and used to coat 384-well plates (Nalge-Nunc, Rochester, N.Y., USA), 4 ° C for 24 h. The plates were washed 2 times with PBS/Tween and blocked by adding 200 l blocking buffer (PBS/1% BSA) for 2 h at room temperature. The plates were washed 4 times with PBS/Tween and 100 l of standards or samples, diluted in PBS/1% BSA/Tween, were added for 24 h at 4 ° C. Plates were washed 4 times and 100 l of detection Abs was added for 1 h at room temperature, washed 6 times and 100 l of a 1: 1,000 dilution of Avidin-HRP (Jackson, Bar Harbor, Me., USA) diluted in PBS/1% BSA/Tween was added to each well for 30 min at room temperature. After washing 6 times 100 l of substrate (100 l of 3% H 2 O 2 to 11 ml 2,2 -azino-bis-3-ethylbenzthiazoline-6-sulfonic acid diluted 0.3 mg/ml in 0.1 M anhydrous citric acid) was added and the OD at 405 nm was measured after 10-20 min.
Basophils were challenged for 30 h in Hanks' balanced salt solution [15] with or without 22E7, anti-IgE, or antigen (Indoor Biotechnologies, Charlottesville, Va., USA). Histamine release was measured as previously described [15] .
To examine the rebound in cellular Syk levels and Fc RI responsiveness, NP-IgE-sensitized mast cells (0.5-10 ! 10 6 cells/ condition) were challenged with or without 0.1 ng/ml of antigen for 24-30 h (to induce desensitization). Cells were washed 3 ! with AIM-V medium and suspended in AIM-V + SCF for the indicated times. Cells were washed 2 ! in protein-free medium and subjected to SDS-PAGE and Western blotting as described below. Duplicate samples, treated in parallel, were resensitized with IgE (10 ng/ ml) and used to determine Fc RI responsiveness with optimal antigen concentrations.
[Ca
2+
] i Measurement using Fura-2 Fluorescence NP-IgE-sensitized mast cells were adhered to coverslips coated with 0.1% gelatin for 24 h. Cells were loaded with the Ca 2+ -sensitive probe Fura-2/acetoxymethy (2 mol/l) for 30 min in a CO 2 incubator at 37 ° C. After loading, cells were washed and incubated in HBSS without cross-linker to obtain a baseline reading followed by the addition of HBSS containing various concentrations of NP-BSA. Intracellular calcium ([Ca 2+ ] i ) was measured using an IX-50 inverted fl uorescence microscope (Olympus, Tokyo, Japan) in conjunction with a xenon arc excitation source, a photomultiplier, and a photon counter (Ionoptix, Milton, Mass., USA). Data were acquired and analyzed with Ionwizard software provided by the manufacturer. Epifl uorescence was measured from 6 5 mast cells, and the values in [Ca 2+ ] i determined as the fl uorescence ratio ( R ) of Ca 2+ -bound Fura-2 (340 nm) to unbound Fura-2 (380 nm), with emission collected at 510 nm. R was converted to free Ca 2+ concentration using an in vitro standard curve generated with a calibration kit (Molecular Probes, Eugene, Oreg., USA).
Small Inhibitory RNA-Mediated Inhibition of Syk Expression
Four pooled SMARTselected human Syk small inhibitory RNA (siRNA) duplexes with UU overhangs and a 5 -phosphate on the antisense strand were obtained from Dharmacon Research, Lafayette, Colo., USA. As a control, four nonspecifi c siRNAs with equal GC content were used. The siRNA duplex was introduced into human skin mast cells using a liposome transfection approach. Liposome/siRNA complexes were formed at room temperature using 5 l of 20 M siRNA, 3 l of LipofectAMINE TM 2000 (Invitrogen), and 100 l of serum-free DMEM culture medium (Invitrogen). The resulting solution was added dropwise to each 24-well culture dish containing ϳ 1 ! 10 5 MCs. The cells were incubated 4 h at 37 ° C. One milliliter of serum-enriched medium was then added, and the cells were cultured for an additional 30 h. The transiently transfected cells were harvested, and IgE-mediated degranulation and cytokine production measured after IgE sensitization. In parallel, the levels of Syk and actin protein were measured using the below SDS-PAGE immunoblot approach.
Western Blotting
Mast cells were lysed in denaturing lysis buffer at 0.5-10 ! 10 7 cells/ml. The protocol for this is described by Tkaczyk et al. [18] . Expression of Syk, Lyn, and actin protein was measured by Western blotting as previously described [12, 15] .
Band intensities were quantitated using a molecular imaging package from Biorad (The Discovery Series, Quantity One, Quantitative Software). In some experiments band intensities are presented as a ratio of Syk to actin to compensate for gel loading and blot stripping/reprobing variations. Degranulation was measured in each Western blotting/immunoprecipitation experiment by measuring ␤ -hexosaminidase as described above.
Results
Fc RI Nonresponsiveness due to Long-Term Antigen Stimulation
The mechanism for Fc RI nonresponsiveness after long-term antigen stimulation is not clear and has not been demonstrated with human mast cells. We tested human skin mast cells for their ability to become unresponsive to IgE stimuli following long-term antigen stimulation. NP IgE-sensitized cells were challenged with or without optimal (10 ng/ml) or suboptimal (0.1 ng/ml) concentrations of NP-BSA up to 52 h. Supernatants were collected after this initial desensitization step and examined for degranulation (prerelease). Cells were resensitized with IgE for 2 h, washed, and rechallenged with optimal concentrations of NP-BSA for 30 min and ␤ -hexosaminidase measured in the supernatants. As expected, no desensitization was observed in cells not exposed to cross-linker ( fi g. 1 a) and optimal concentrations of antigen induced robust degranulation ( fi g. 1 c). As shown in fi gure 1 b, Fc RI-mediated degranulation was optimally inhibited when cells were fi rst exposed to suboptimal concentrations of antigen for 24 h. This nonresponsiveness was not simply due to the loss of IgE as Previous studies showed decreased levels of Syk protein were associated with human basophil Fc RI nonresponsiveness [12, 19] and human mast cells may have a similar nonreleaser phenotype [13] . Thus, it was hypothesized that nonresponsive skin mast cell Fc RI induced by suboptimal antigen stimulation was due to decreased Syk levels. As shown in fi gure 2 a, NP-IgE-sensitized skin mast cells begin to lose Syk expression at antigen concentrations which did not induce detectable degranulation and 10,000 times less (0.001 ng/ml) than that required for optimal degranulation (10 ng/ml). Syk was decreased in cells challenged from 0.0001 to 10 ng/ml of antigen for 24 h, while Lyn levels remained unchanged. High doses of antigen ( 1 100 ng/ml), which causes excessive receptor cross-linking and reduced mediator release, did not re- for 24-30 h and Syk expression examined by Western blot. As seen in fi gure 2 c, basophil Syk is reduced in response to IgE-mediated stimulation. As with mast cells, Syk reduction occurred at antigen concentrations that did not induce noticeable degranulation (0.01 ng/ml). These results suggest that suboptimal Fc RI cross-linking induces basophil nonresponsiveness through a mechanism which reduces Syk levels. In addition, reduced Syk levels due to low concentrations of IgE receptor cross-linker may be a common mechanism regulating human Fc RI cellular responsiveness.
Reduction in Syk Levels and Cytokine Release from Human Skin Mast Cells
We next determined if Syk reduction occurred at antigen concentrations which induce mast cell cytokine production. As seen in fi gure 3 , densitometric analysis demonstrated reduced Syk levels at antigen concentrations that did not induce degranulation or the production and secretion of TNF-␣ and GM-CSF. Similar results were obtained with IL-5 cytokine production (data not shown). Thus, suboptimal doses of antigen induce Syk reduction at concentrations 1,000 times less than that required for cytokine production.
Syk Is Reduced with Suboptimal Antigen Stimulation through a Calcium-Independent, ProteasomeDependent Mechanism
The mechanism leading to antigen-induced Syk deficiency was further explored. Reduced Syk levels with suboptimal antigen concentrations (0.001-0.1 ng/ml) occurred at concentrations that were independent of the ] i in response to suboptimal concentrations inducing Syk defi ciency (0.001 and 0.01 ng/ml) for longer periods of time (up to 6 h) failed to detect store release (not shown). As seen in fi gure 4 b, skin mast cells incubated with suboptimal antigen had low levels of Syk. However, Syk levels and IgE-mediated degranulation were increased under these conditions if the proteasome inhibitors PSI or MG-132 were added to the cells before Fc RI challenge. We also observed similar Syk mRNA levels in cells challenged with suboptimal antigen concentrations and nonchallenged cells (data not shown). These results suggest that mast cell challenge with suboptimal antigen concentrations induces a reduction in Syk protein through a posttranslational, proteasome-dependent mechanism.
A Rebound in Cellular Syk Correlates with Fc RI Responsiveness
Based on the observation that antigen-induced Fc RI nonresponsiveness correlated with reduced Syk levels, we investigated if a rebound in Syk levels correlated with the loss of Fc RI nonresponsiveness. IgE-sensitized mast cells were challenged with suboptimal antigen concentrations as above. Cells were washed free of antigen. IgE- To further determine a cause and effect relationship between reduced Syk levels and inhibition of mast cell mediator release we used siRNA to evaluate the consequences of decreased Syk expression in human skin mast cells. As seen in fi gure 5 b, inhibition of Syk expression in skin mast cells resulted in an inhibition of IgE-mediated degranulation and cytokine production. The siRNA treatment did not affect total ␤ -hexosaminidase levels inside the cell (data not shown). These data further support a critical role of Syk in human mast cell signal transduction. In addition, these are the fi rst data demonstrating the ability of skin mast cells to be transfected with siRNA duplexes.
Discussion
We previously showed that nonreleaser basophils, which also demonstrate Fc RI nonresponsiveness, had reduced Syk levels [12, 19] . We hypothesized that low concentrations of antigen could induce Fc RI nonresponsiveness through a reduction in Syk protein.
In the studies presented here we demonstrate that human skin mast cell Fc RI becomes nonresponsive with antigen concentrations that do not induce signifi cant mediator release. This nonresponsiveness correlates with reduced levels of Syk, similar to nonreleaser basophils. Low concentrations of antigen also lead to reduced Syk levels in peripheral blood basophils. Syk appears to be downregulated through proteasome degradation as agents that block these events also block Syk reduction. The initial steps leading to Syk reduction appear to be calcium independent. When antigen is removed the mast cells become responsive to IgE-mediated stimuli after 24 h in culture. The loss of Fc RI nonresponsiveness paralleled increases in Syk levels. The observation that reduced Syk levels occurs at the protein level is similar to those observed in nonreleaser basophils [19] [20] [21] .
Our data demonstrates that the loss of Syk occurs only after prolonged incubation with antigen. This is very different from what was reported in the original description of 'desensitization' of basophils [22] [23] [24] . In these studies desensitization occurred within minutes when the cells were challenged with antigen in the absence of calcium.
This acute mechanism for Fc RI downregulation does not appear to involve Fc RI/antigen internalization or Syk loss. Recent studies by MacGlashan [25] demonstrated that antigen stimulation of basophils induces downregulation operating before or at the level of Syk phosphorylation. In these experiments basophils were challenged with antigen for less than 2 h before challenge with anti-IgE. The levels of Syk phosphorylation were transient with antigen stimulation and no reduction in Syk levels was noted, probably due to the reduced prechallenge time.
Recent studies by this group found that optimal and suboptimal concentrations of antigen led to reduced Syk expression similar to what was observed in the present study ( fi g. 2 c) [21] . The studies presented here confi rm the studies in basophils and extend these observations in skin mast cells. Taken together, these results suggest reductions in Syk levels through antigen stimulation may act to keep these infl ammatory cells in a quiescent state.
We also observed that Syk levels were lower in mast cells/basophils that were optimally challenged with antigen but had maximal mediator release. This is not surprising in that degranulation occurs within 30 min following activation while cytokine production occurs after 24 h. Therefore, there are likely adequate amounts of Syk protein to mediate the signaling cascade leading to mediator release.
We observed that antigen-induced Syk reduction was mediated through ubiquitination and proteasomal degradation. Rodent mast cell-like cells (RBL-2H3) and human basophils demonstrated Syk ubiquitination after Fc RI engagement with optimal concentrations of antigen and suggest a similar molecular mechanism for downregulation of receptor complexes by targeting ubiquitinated Syk to the proteasome for degradation [21, 26] . The mechanisms presented here and previously may explain how a 'resting' cell remains nonactivated after suboptimal antigen challenge while Syk reduction with optimal concentrations of antigen is consistent with a mechanism for 'turning off' ongoing mast cell mediator responses.
The precedence for selective protein degradation through activation of immune receptors is strong. Ubiquitination is a posttranslational modifi cation that controls the fate of proteins through selective proteasome degradation. In antigen-stimulated T cells, ZAP-70 (a kinase similar to Syk) is rapidly degraded via a calpain-dependent mechanism [27] . Paolini and Kinet [28] found Fc RI engagement on RBL-2H3 resulted in Syk ubiquitination and Syk kinase activity is required for its own ubiquitination [29] . Similarly, B cell receptor stimulation induces Syk ubiquitination [30, 31] . Others have shown that both Syk and ZAP-70 become ubiquitinated in response to antigen stimulation in other cell types [32] . Receptor-mediated activation of other kinases similarly 'tags' them for ubiquitination-dependent degradation [26, 33, 34] .
It is possible that low concentrations of antigen induces IgE nonresponsiveness through a Syk-independent mechanism. However, we showed that reducing the level of Syk with siRNA correlated with reduced IgE signaling leading to mediator release ( fi g. 5 b). This was expected as we and others have demonstrated that Fc RI-induced mediator release is dependent on the levels of Syk protein [12, 20, 35] . Reduction in levels of other molecules leading to a lack of IgE-mediated degranulation have been reported in rodent cells [36, 37] , while Lyn defi ciency appears to have little affect [38] . Nonetheless, adequate quantities of Syk are clearly required for a full response through Fc RI on human mast cells.
The implications for these studies are far-reaching. No hypothesis has been able to explain how graded increases in allergen dosing (up to 15-20 g of major allergen) given during immunotherapy can be injected without inducing anaphylaxis. It has been assumed that as the dose of allergen is slowly titrated up, some degree of 'tolerance' is induced which renders the next dose safe. It is plausible that the mechanisms underlying chronic allergen stimulation and concomitant Fc RI nonresponsiveness may involve decreased Syk levels resembling nonreleaser mast cells/basophils. How could chronic, low-dose antigen stimulation induce degradation of Fc RI-specifi c kinases without affecting protein levels in other cells (as with nonreleaser basophils and possibly mast cells)? The following hypothesis is proposed ( fi g. 6 ).
Allergen immunotherapy, which aims to induce Fc RI nonresponsiveness with suboptimal doses of antigen, initially induces antigen-specifi c IgE and is given at a dose that does not result in noticeable symptoms. Fatalities have been associated with allergen skin testing and immunotherapy; thus ensuring the patient receives a dose of allergen that will induce desensitization -but not anaphylaxis -is an important safety concern. Low IgE-Fc RI cross-linking leads to the downregulation and degradation of Fc RI receptor-associated kinases through ubiquitination and proteasome degradation. The recurrent stimulation (induction involves weekly shots) with increasing doses of allergen would ensure continued, subacute activation and kinase ubiquitination, while the specifi c, high-affi nity interaction between mast cell/basophil surface IgE with antigen would ensure only downregulation of kinase levels in these cells. In preliminary experiments we found that donors undergoing specifi c allergy vaccination have reduced basophil histamine release (as others have found [9] ) and undetectable levels of Syk during the initial up-dosing period (Kepley, unpubl. data) . The data presented here and previously [21] provide mechanistic evidence to support the above hypothesis.
In conclusion, we show that proteasome-mediated degradation of Fc RI-associated Syk with low concentrations of antigen, for extended periods of time, leads to Fc RI nonresponsiveness on mast cells. We also confi rm previous studies in human basophils by demonstrating that antigen challenge induces reductions in Syk protein levels. The resulting reduction in kinase levels would blunt the signaling process and inhibit IgE cell responsiveness to antigenic stimulation. This mechanism may account for the clinical success observed during the initial, 'up-dosing' that occurs with allergen immunotherapy.
